Medidata Remote Source Review Software-as-a-Service for Electronic Monitoring of Clinical Studies Presolicitation
Closed Pre-Solicitation Posted
- Solicitation number
- NIAID-NOI-26-2277939
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 513210 Software Publishers
- Place of performance
- Rockville, Maryland 20852, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, is seeking to procure Medidata Remote Source Review Software-as-a-Service licenses to support clinical site monitoring activities within the Division of AIDS. This is a sole-source acquisition under Federal Acquisition Regulation 13.106-1(b)(2), with NIAID designating Medidata Solutions, Inc. as the only responsible source capable of satisfying the agency's requirements. The procurement will provide Remote Source Review capabilities in a validated environment that complies with federal and international regulatory standards. The contract will operate on a firm-fixed price basis with performance spanning six months from January 1, 2026 through June 30, 2026. The government plans to complete contract award within fifteen days of this notice, which was posted on December 11, 2025, with interested parties able to express capability through December 20, 2025.
This acquisition includes no set-aside designation, and Medidata Solutions, Inc. has been identified as the incumbent contractor and sole-source provider. The Bill of Materials specifies four contract line items encompassing 50 subscription services for Remote Source Review study lanes, 10 professional services for new study builds, 50 professional services for post go-live support, and 2 professional services for simple study updates across the six-month performance period. No specific budget range is disclosed in the pre-solicitation notice, though the acquisition is classified under NAICS code 513210 (Software Publishers) with a size standard of $47.0 million, with Medidata Solutions identified as an other than small business. The contract represents a renewal of existing software licenses and related professional services rather than a new procurement initiative.
Notice text
THIS IS A NOTICE OF INTENT AND NOT A REQUEST FOR QUOTATIONS
This notice is published in accordance with Federal Acquisition Regulation (FAR) 5.101(a)(1) requiring the dissemination of information regarding proposed contract actions. This is a Notice of Intent to award a sole source, firm-fixed price purchase order under the authority of 41 U.S.C. 1901, as implemented by FAR 13.106-1(b)(2) and 13.501(a) - Only One Responsible Source and No Other Supplies or Service Will Satisfy Agency Requirements and is not a request for competitive quotes.
The National Institute of Allergy and Infectious Diseases (NIAID) intends to negotiate on a sole source basis with Medidata Solutions, Inc. 350 Hudson St. #9, New York, New York 10014. This acquisition will renew Medidata Remote Source Review module licenses to manage clinical site monitoring performed by the Division of AIDS within the National Institute of Allergy and Infectious Diseases in a validated environment in accordance with federal and international regulations. NIAID requires the procurement of Medidata licenses to continue to provide Remote Source Review capabilities as described on the attached Bill of Materials for a 6-month period with a period of performance of 1/1/2026 to 6/30/2026.
The North American Industry Classification (NAICS) code for this acquisition is 513210 Software Publishers, which has a size standard of $47.0 million. Medidata Solutions is an other than small business.
This will be the only notice of the Government's intent to solicit, negotiate, and award to one source to satisfy this requirement. The Government plans to award a contract for this requirement within fifteen (15) days of this notice.
While this synopsis does not constitute a solicitation, interested vendors may identify their interest and capability to satisfy this requirement. The Government understands that Medidata Solutions is the only vendor who can provide the requested services for NIAID. However, firms that believe they can provide the capability required to fully meet the Government's requirement may submit a capabilities statement, including past performance, in writing to the identified point of contact within 15 days after publication of this notice. Such documentation shall be evaluated solely for the purpose of determining whether or not to conduct this procurement on a competitive basis. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. Interested parties may identify their interest and capability to respond to the requirement or submit offers on NOI-NIAID-26-2277939.
This notice does not obligate the Government to award a contract or otherwise pay for any information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted.
For additional information or to submit responses, please contact Linda Smith, Contracting Officer at Linda.smith2@nih.gov.
Files
| File | Type | Posted |
|---|---|---|
| BOM Medidata RSR (FY26).xlsx | XLSX spreadsheet |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Pre-Clinical Models of Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside | |
| 2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside | |
| Sirturo (Bedaquiline) tablets for the NIH (Notice of Intent to sole source) | NIH Clinical Center | No set-aside | |
| CDC Typefi Orion Cloud Teams | — | No set-aside | |
| FDA Scientific & Regulatory Support Services(SRS) | FDA Office of Acquisition and Grant Services | Total Small Business |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity